AMGEN INC's ticker is and the CUSIP is 031162900. A total of 12 filers reported holding AMGEN INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,918,308 | -25.2% | 18,300 | -38.2% | 0.02% | -19.0% |
| Q2 2023 | $6,571,792 | -74.5% | 29,600 | -72.3% | 0.02% | -77.4% |
| Q1 2023 | $25,794,725 | -71.1% | 106,700 | -68.7% | 0.09% | -55.3% |
| Q4 2022 | $89,402,656 | +60.1% | 340,400 | +37.4% | 0.21% | +89.1% |
| Q3 2022 | $55,832,000 | +4.9% | 247,700 | +13.2% | 0.11% | +32.5% |
| Q2 2022 | $53,234,000 | +6.3% | 218,800 | +5.6% | 0.08% | +66.0% |
| Q1 2022 | $50,081,000 | -9.4% | 207,100 | -15.7% | 0.05% | +13.6% |
| Q4 2021 | $55,275,000 | +55.3% | 245,700 | +46.8% | 0.04% | +15.8% |
| Q3 2021 | $35,598,000 | -10.9% | 167,400 | +2.1% | 0.04% | -20.8% |
| Q2 2021 | $39,975,000 | +21.1% | 164,000 | +23.6% | 0.05% | -2.0% |
| Q1 2021 | $33,017,000 | +99.7% | 132,700 | +84.6% | 0.05% | +69.0% |
| Q4 2020 | $16,531,000 | -37.2% | 71,900 | -30.6% | 0.03% | -65.1% |
| Q3 2020 | $26,331,000 | +2.4% | 103,600 | -5.0% | 0.08% | -30.3% |
| Q2 2020 | $25,709,000 | +43.3% | 109,000 | +23.2% | 0.12% | -17.9% |
| Q1 2020 | $17,942,000 | +5.9% | 88,500 | +25.9% | 0.14% | +26.1% |
| Q4 2019 | $16,947,000 | +220.8% | 70,300 | +157.5% | 0.12% | +167.4% |
| Q3 2019 | $5,283,000 | -47.4% | 27,300 | -49.9% | 0.04% | -52.7% |
| Q2 2019 | $10,043,000 | +468.4% | 54,500 | +486.0% | 0.09% | +355.0% |
| Q1 2019 | $1,767,000 | -70.1% | 9,300 | -69.4% | 0.02% | -60.8% |
| Q4 2018 | $5,918,000 | -10.8% | 30,400 | -5.0% | 0.05% | -1.9% |
| Q3 2018 | $6,633,000 | -6.9% | 32,000 | -17.1% | 0.05% | -14.8% |
| Q2 2018 | $7,125,000 | +16.7% | 38,600 | +7.8% | 0.06% | 0.0% |
| Q1 2018 | $6,103,000 | +3.2% | 35,800 | +5.3% | 0.06% | +45.2% |
| Q4 2017 | $5,913,000 | +27.4% | 34,000 | +36.5% | 0.04% | 0.0% |
| Q3 2017 | $4,643,000 | -22.3% | 24,900 | -28.2% | 0.04% | -32.3% |
| Q2 2017 | $5,976,000 | +171.8% | 34,700 | +159.0% | 0.06% | +138.5% |
| Q1 2017 | $2,199,000 | +106.1% | 13,400 | +83.6% | 0.03% | +160.0% |
| Q4 2016 | $1,067,000 | +535.1% | 7,300 | +329.4% | 0.01% | +150.0% |
| Q2 2013 | $168,000 | – | 1,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PFM Health Sciences, LP | 176,600 | $32,544,000 | 0.62% |
| Partner Investment Management, L.P. | 3,000 | $553,000 | 0.59% |
| WINTRUST INVESTMENTS LLC | 12,000 | $2,318,000 | 0.35% |
| GROUP ONE TRADING, L.P. | 54,500 | $10,043,000 | 0.09% |
| SIMPLEX TRADING, LLC | 1,688 | $31,106,000 | 0.08% |
| IMC-Chicago, LLC | 57,000 | $10,504,000 | 0.03% |
| Gladius Capital Management LP | 2,100 | $392,000 | 0.02% |
| Allianz Asset Management GmbH | 90,900 | $16,751,000 | 0.02% |
| JPMORGAN CHASE & CO | 149,800 | $27,566,000 | 0.01% |
| SG Americas Securities, LLC | 32,400 | $102,000 | 0.00% |